Combination Antithrombotic Therapies

被引：93
作者：
Gurbel, Paul A. [1 ]
Tantry, Udaya S. [1 ]
机构：
[1] Sinai Hosp, Sinai Ctr Thrombosis Res, Cardiac Catheterizat Labs, Baltimore, MD 21215 USA
来源：
CIRCULATION | 2010年 / 121卷 / 04期
关键词：
platelets; thrombosis; coronary artery disease; aspirin; thienopyridine; bleeding; PERCUTANEOUS CORONARY INTERVENTION; DUAL ANTIPLATELET THERAPY; ELEVATION MYOCARDIAL-INFARCTION; MAINTENANCE-DOSE CLOPIDOGREL; P2Y(12) RECEPTOR ANTAGONIST; ELUTING STENT IMPLANTATION; TRANSIENT ISCHEMIC ATTACK; HIGH-RISK PATIENTS; PLATELET-AGGREGATION; DOUBLE-BLIND;
D O I：
10.1161/CIRCULATIONAHA.109.853085
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：569 / 583
页数：15
相关论文
共 113 条
[91]   A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents [J].
Schomig, A ;
Neumann, FJ ;
Kastrati, A ;
Schuhlen, H ;
Blasini, R ;
Hadamitzky, M ;
Walter, H ;
ZitzmannRoth, EM ;
Richardt, G ;
Alt, E ;
Schmitt, C ;
Ulm, K .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (17) :1084-1089
[92]   Ticlopidine versus aspirin after myocardial infarction (STAMI) trial [J].
Scrutinio, D ;
Cimminiello, C ;
Marubini, E ;
Pitzalis, MV ;
Di Biase, M ;
Rizzon, P .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (05) :1259-1265
[93]   Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy [J].
Shuldiner, Alan R. ;
O'Connell, Jeffrey R. ;
Bliden, Kevin P. ;
Gandhi, Amish ;
Ryan, Kathleen ;
Horenstein, Richard B. ;
Damcott, Coleen M. ;
Pakyz, Ruth ;
Tantry, Udaya S. ;
Gibson, Quince ;
Pollin, Toni I. ;
Post, Wendy ;
Parsa, Afshin ;
Mitchell, Braxton D. ;
Faraday, Nauder ;
Herzog, William ;
Gurbel, Paul A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (08) :849-858
[94]   Calcium-Channel Blockers Reduce the Antiplatelet Effect of Clopidogrel [J].
Siller-Matula, Jolanta M. ;
Lang, Irene ;
Christ, Guenter ;
Jilma, Bernd .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (19) :1557-1563
[95]   Genetic Determinants of Response to Clopidogrel and Cardiovascular Events. [J].
Simon, Tabassome ;
Verstuyft, Celine ;
Mary-Krause, Murielle ;
Quteineh, Lina ;
Drouet, Elodie ;
Meneveau, Nicolas ;
Steg, P. Gabriel ;
Ferrieres, Jean ;
Danchin, Nicolas ;
Becquemont, Laurent .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (04) :363-375
[96]   Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention - A randomized controlled trial [J].
Steinhubl, SR ;
Berger, PB ;
Mann, JT ;
Fry, ETA ;
DeLago, A ;
Wilmer, C ;
Topol, EJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (19) :2411-2420
[97]   Inhibition of platelet aggregation by AZD6140, A reversible oral P2Y12 receptor antagonist, compared with clopidogral in patients with acute coronary syndrome [J].
Storey, Robert F. ;
Husted, Steen ;
Harrington, Robert A. ;
Heptinstall, Stanley ;
Wilcox, Robert G. ;
Peters, Gary ;
Wickens, Mark ;
Emanuelsson, Hakan ;
Gurbel, Paul ;
Grande, Peer ;
Cannon, Christopher P. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (19) :1852-1856
[98]  
TAKEUCHI M, 2007, EUR SOC CARD C SEPT
[99]   AZD6140 [J].
Tantry, Udaya S. ;
Bliden, Kevin P. ;
Gurbel, Paul A. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (02) :225-229
[100]   Antiplatelet therapy: current strategies and future trends [J].
Tantry, Udaya S. ;
Etherington, Amena ;
Bliden, Kevin P. ;
Gurbel, Paul A. .
FUTURE CARDIOLOGY, 2006, 2 (03) :343-366
3456789101112